🔎 Trials Near Me

Home › Refractory Anemia na May Sobrang Blasts › Washington

Pag-aaral pangklinika para sa Refractory Anemia na May Sobrang Blasts sa Washington

5 pag-aaral para sa Refractory Anemia na May Sobrang Blasts ang naghahanap ng mga kalahok sa mga site sa Washington.

Mga Lungsod sa Washington

Opisyal na teksto ng pag-aaral (English)

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT03670966

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT03128034

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Seattle Cancer Care Alliance, Seattle
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • Fred Hutchinson Cancer Center, Seattle
Nagre-recruitPhase 2
Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • Fred Hutchinson Cancer Research Center, Seattle
Nagre-recruitPhase 2
3 Months · Lahat ng kasarian · Na-update Nob 12, 2025 · NCT02143830

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.